Q1 Results: Biocon Sees Two Segments Driving Its Growth In 2019-20
Kiran Mazumdar Shaw, chairperson and managing director of Biocon Ltd.(Photographer: Namas Bhojani/Bloomberg)

Q1 Results: Biocon Sees Two Segments Driving Its Growth In 2019-20

Biocon Ltd. expects its biologics and small molecules businesses to continue its growth momentum in 2019-20, Chairperson and Managing Director Kiran Mazumdar Shaw said on Friday.The company is seei...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.